Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
BMC Cancer
|
March 7, 2014
Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group
Thanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, et al.
Anti-Cancer Drugs
|
November 6, 2009
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution
Jérôme Fayette, Helen Boyle, Sylvie Chabaud, et al.
Plos One
|
May 21, 2020
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)
Mehdi Brahmi, Philippe Cassier, Armelle Dufresne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patients
Julien Péron, Claire Cropet, Olivier Tredan, et al.
The Lancet. Oncology
|
April 13, 2016
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
Olivier Mir, Claire Cropet, Maud Toulmonde, et al.
Cell Death and Differentiation
|
June 2, 2018
The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death
Jonathan Vial, Amélie Royet, Philippe Cassier, et al.
Head & Neck
|
October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol
Elise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
Plos One
|
February 4, 2017
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)
Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.
BMC Cancer
|
February 8, 2013
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
Jean-Yves Blay, Antoine Italiano, Isabelle Ray-Coquard, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
BMC Cancer
|
March 7, 2014
Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group
Thanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, et al.
Anti-Cancer Drugs
|
November 6, 2009
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution
Jérôme Fayette, Helen Boyle, Sylvie Chabaud, et al.
Plos One
|
May 21, 2020
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)
Mehdi Brahmi, Philippe Cassier, Armelle Dufresne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patients
Julien Péron, Claire Cropet, Olivier Tredan, et al.
The Lancet. Oncology
|
April 13, 2016
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
Olivier Mir, Claire Cropet, Maud Toulmonde, et al.
Cell Death and Differentiation
|
June 2, 2018
The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death
Jonathan Vial, Amélie Royet, Philippe Cassier, et al.
Head & Neck
|
October 13, 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol
Elise Rowinski, Nicolas Magné, Jérôme Fayette, et al.
Plos One
|
February 4, 2017
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)
Olfa Derbel, Pierre Etienne Heudel, Claire Cropet, et al.
BMC Cancer
|
February 8, 2013
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
Jean-Yves Blay, Antoine Italiano, Isabelle Ray-Coquard, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Page
of 6